Ambu A/S 1/30/2024 Earnings Report

Ambu A/S EPS Results

• Actual EPS: $0.05
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Ambu A/S Revenue Results

• Actual Revenue: $181.02 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Ambu A/S Announcement Details

• Date: 1/30/2024
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Ambu A/S (OTCMKTS:AMBBY) is a global medical device company specializing in the development, manufacture and distribution of single‐use endoscopy, anesthesia and patient monitoring solutions. Its core product portfolio includes single‐use bronchoscopes, duodenoscopes and cystoscopes designed to reduce the risk of cross‐contamination and lower total cost of ownership for hospitals and clinics. In addition to endoscopy, Ambu offers a range of products for anesthesia and resuscitation, such as face masks, laryngeal masks and intubation devices, along with diagnostic tools including electrocardiogram (ECG) electrodes and sleep diagnostics equipment.

Founded in 1937 in Denmark, Ambu has evolved from supplying reusable technical medical devices to pioneering disposable technologies that address infection control and workflow efficiency. Over the decades, the company has expanded its global footprint through strategic investments in research and development as well as targeted acquisitions. Ambu’s products are marketed in more than 100 countries across Europe, the Americas and the Asia‐Pacific region, supported by a network of subsidiaries and distribution partners that enable local customer service, training and technical support.

Headquartered in Ballerup, Denmark, Ambu employs a diverse workforce of research scientists, engineers and healthcare specialists dedicated to advancing patient safety and clinical performance. The company’s executive leadership team is led by CEO Peter Buhl Nielsen, under whose direction Ambu has intensified its focus on innovation in single‐use endoscopy and strengthened its competitive position through collaborations with healthcare providers. Ambu continues to invest in cutting‐edge technologies and sustainable manufacturing practices to address evolving healthcare needs and regulatory requirements worldwide.